PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer

SIMPLE SUMMARY: Over the last decade, immune checkpoint inhibitors (ICIs) targeting programmed death 1 (PD-1), programmed death-ligand 1 (PD-L1), and cytotoxic T-lymphocyte antigen 4 (CTLA-4) have dramatically changed the therapeutic algorithm of several hematological and solid tumors. Of note, thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizzo, Alessandro, Ricci, Angela Dalia, Brandi, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867133/
https://www.ncbi.nlm.nih.gov/pubmed/33535621
http://dx.doi.org/10.3390/cancers13030558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867133/
https://www.ncbi.nlm.nih.gov/pubmed/33535621
http://dx.doi.org/10.3390/cancers13030558

Ejemplares similares